Oxford Finance Team Life Sciences Healthcare News Contact Us A Partner Who Knows Life Sciences Early-stage, late-stage private and public companies of all sizes rely on our life sciences sector knowledge and strategic insight to craft the financial instruments that best serve their business goals. Oxford Finance is a reliable, trusted partner to venture capital firms, management teams, entrepreneurs and other lenders. From Early Stage to IPO and Beyond. Our focus is on life sciences, across a range of sub-sectors: Biopharmaceuticals Medical Devices Specialty Pharmaceuticals Enabling Technologies & Tools Diagnostics Healthcare IT Loan Products Clients work with dedicated teams of professionals through the entire loan process. Our collaborative approach ensures that the loan terms meet a client’s needs – and exceed its expectations. Our teams are empowered to work efficiently and thoroughly, with no bureaucratic layers, so we can deliver what we promise. Senior Secured Term Loan Three-to five-year term Used for general working capital purposes, product licensing or acquisition opportunities Cash Flow Loan Three- to five-year term Used to support acquisitions, refinancing and company growth Revolving Line of Credit Two-to-five-year line of credit Ability to draw from and repay the balance repeatedly over the term of the loan Used for working capital and company growth Download Life Sciences Brochure Recent Transactions View All Download Transaction Sheet Peter Lawrence President & COO, ArQule, Inc. I have a long track record with Oxford, and have found them very easy to work with and competitively priced. They know the life sciences space, and have the flexibility and patience needed to support start-ups through the various stages of development. Richard Buchholz Chief Financial Officer, Inspire Medical Systems 1 2 3 4 View All Client References Meet the Life Sciences Team View All Team Members Recent Life Science News November 10th, 2021 Oxford Finance Provides $50 Million Credit Facility to Kezar Life Sciences, Inc. News | Biotech & Specialty Pharmaceuticals | Life Sciences November 9th, 2021 Oxford Finance Closes $20 Million Credit Facility with PlateletBio News | Biotech & Specialty Pharmaceuticals | Life Sciences November 5th, 2021 Viracta Therapeutics Secures $50 Million Credit Facility from Silicon Valley Bank and Oxford Finance News | Biotech & Specialty Pharmaceuticals | Life Sciences View All © 2021 Oxford Finance LLC Privacy Policy Terms of Service Loans made or arranged pursuant to a California Financing Law License. Home Team Life Sciences Healthcare News Contact Us